IRIS Accounts Production v25.2.0.378 11683385 director 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh116833852024-03-31116833852025-03-31116833852024-04-012025-03-31116833852023-03-31116833852023-04-012024-03-31116833852024-03-3111683385ns15:EnglandWales2024-04-012025-03-3111683385ns14:PoundSterling2024-04-012025-03-3111683385ns10:Director12024-04-012025-03-3111683385ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3111683385ns10:SmallEntities2024-04-012025-03-3111683385ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3111683385ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3111683385ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3111683385ns10:FullAccounts2024-04-012025-03-311168338512024-04-012025-03-3111683385ns10:RegisteredOffice2024-04-012025-03-3111683385ns5:CurrentFinancialInstruments2025-03-3111683385ns5:CurrentFinancialInstruments2024-03-3111683385ns5:ShareCapital2025-03-3111683385ns5:ShareCapital2024-03-3111683385ns5:RetainedEarningsAccumulatedLosses2025-03-3111683385ns5:RetainedEarningsAccumulatedLosses2024-03-3111683385ns5:NetGoodwill2024-04-012025-03-3111683385ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111683385ns5:ComputerEquipment2024-04-012025-03-3111683385ns5:NetGoodwill2024-03-3111683385ns5:NetGoodwill2025-03-3111683385ns5:NetGoodwill2024-03-3111683385ns5:ComputerEquipment2024-03-3111683385ns5:ComputerEquipment2025-03-3111683385ns5:ComputerEquipment2024-03-3111683385ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-31116833851ns10:Director12024-03-31116833851ns10:Director12023-03-31116833851ns10:Director12024-04-012025-03-31116833851ns10:Director12023-04-012024-03-31116833851ns10:Director12025-03-31116833851ns10:Director12024-03-31
REGISTERED NUMBER: 11683385 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Alpha Omega Pathology Ltd

Alpha Omega Pathology Ltd (Registered number: 11683385)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Alpha Omega Pathology Ltd

Company Information
for the Year Ended 31 March 2025







DIRECTOR: Doctor H M Burnley





REGISTERED OFFICE: 31 Alison Way
Winchester
Hampshire
SO22 5BT





REGISTERED NUMBER: 11683385 (England and Wales)





ACCOUNTANTS: Thomas Croft Limited
Accountants And Taxation Consultants
Solent House
107a Alma Road
Portswood
Southampton
Hampshire
SO14 6UY

Alpha Omega Pathology Ltd (Registered number: 11683385)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 1,141 1,770
1,141 1,770

CURRENT ASSETS
Stocks - 2,400
Debtors 6 19,420 2,175
Cash at bank 304,221 282,023
323,641 286,598
CREDITORS
Amounts falling due within one year 7 36,219 44,032
NET CURRENT ASSETS 287,422 242,566
TOTAL ASSETS LESS CURRENT
LIABILITIES

288,563

244,336

CAPITAL AND RESERVES
Called up share capital 265 265
Retained earnings 8 288,298 244,071
SHAREHOLDERS' FUNDS 288,563 244,336

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Alpha Omega Pathology Ltd (Registered number: 11683385)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 August 2025 and were signed by:





Doctor H M Burnley - Director


Alpha Omega Pathology Ltd (Registered number: 11683385)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Alpha Omega Pathology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2018, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Stocks
Work in progress is valued at the lower of cost and net realisable value.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Alpha Omega Pathology Ltd (Registered number: 11683385)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 25,000
AMORTISATION
At 1 April 2024
and 31 March 2025 25,000
NET BOOK VALUE
At 31 March 2025 -
At 31 March 2024 -

5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2024
and 31 March 2025 2,494
DEPRECIATION
At 1 April 2024 724
Charge for year 629
At 31 March 2025 1,353
NET BOOK VALUE
At 31 March 2025 1,141
At 31 March 2024 1,770

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 19,420 2,175

Alpha Omega Pathology Ltd (Registered number: 11683385)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Corporation tax 31,676 38,628
Directors' current accounts 3,346 4,256
Accrued expenses 1,197 1,148
36,219 44,032

8. RESERVES
Retained
earnings
£   

At 1 April 2024 244,070
Profit for the year 101,388
Dividends (57,160 )
At 31 March 2025 288,298

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
Doctor H M Burnley
Balance outstanding at start of year (4,256 ) (2,149 )
Amounts advanced 4,256 2,149
Amounts repaid (3,346 ) (4,256 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (3,346 ) (4,256 )

10. RELATED PARTY DISCLOSURES

During the year, total dividends of £48,500 were paid to the director .

The company was under the control of Dr H M Burnley throughout the current period. Dr H M Burnley is the managing director and majority shareholder.

No transactions with related parties were undertaken such as are required to be disclosed under Section 1a (Small entities) for Financial Reporting Standard 102.